Yuejun Han

Jinhua, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Zeaxanthin Suppresses Azoxymethane/Dextran Sodium Sulfate-Induced Colorectal Cancer in Mice by Inhibiting Inflammation and Proliferation.

Zeaxanthin Suppresses Azoxymethane/Dextran Sodium Sulfate-Induced Colorectal Cancer in Mice by Inhibiting Inflammation and Proliferation.

Journal: The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
Published: August 04, 2026

Prognostic value of tertiary lymphoid structures in high-risk esophageal squamous cell carcinoma following neoadjuvant chemoimmunotherapy.

Prognostic value of tertiary lymphoid structures in high-risk esophageal squamous cell carcinoma following neoadjuvant chemoimmunotherapy.

Journal: BMC cancer
Published: June 07, 2026

Platinum-free triplet therapy with nab-paclitaxel, S-1, and tislelizumab as first-line treatment for advanced gastric/gastroesophageal junction adenocarcinoma: a phase ii single-arm trial.

Platinum-free triplet therapy with nab-paclitaxel, S-1, and tislelizumab as first-line treatment for advanced gastric/gastroesophageal junction adenocarcinoma: a phase ii single-arm trial.

Journal: BMC cancer
Published: October 10, 2025

Neoadjuvant sintilimab, albumin-bound paclitaxel, and carboplatin for locally advanced, resectable esophageal squamous cell carcinoma: clinical study and mechanistic exploration.

Neoadjuvant sintilimab, albumin-bound paclitaxel, and carboplatin for locally advanced, resectable esophageal squamous cell carcinoma: clinical study and mechanistic exploration.

Journal: NPJ precision oncology
Published: August 15, 2025

Colorectal Cancer Puzzle: m6A Modification and Its Intricate Relationship With Drug Resistance.

Colorectal Cancer Puzzle: m6A Modification and Its Intricate Relationship With Drug Resistance.

Journal: Frontiers in bioscience (Landmark edition)
Published: August 13, 2025

The immune signatures predict gastric/gastroesophageal junction cancer response to first-line anti-PD-1 blockade or chemotherapy.

The immune signatures predict gastric/gastroesophageal junction cancer response to first-line anti-PD-1 blockade or chemotherapy.

Journal: BMC cancer
Published: June 09, 2025

Exosomes in cancer diagnosis based on the Latest Evidence: Where are We?

Exosomes in cancer diagnosis based on the Latest Evidence: Where are We?

Journal: International immunopharmacology
Published: March 21, 2024

Integration of liquid biopsy and immunotherapy: opening a new era in colorectal cancer treatment.

Integration of liquid biopsy and immunotherapy: opening a new era in colorectal cancer treatment.

Journal: Frontiers in immunology
Published: September 12, 2023

From organ preservation to selective surgery: How immunotherapy changes colorectal surgery?

From organ preservation to selective surgery: How immunotherapy changes colorectal surgery?

Journal: Surgery open science
Published: July 28, 2023

It's high-time to re-evaluate the value of induced-chemotherapy for reinforcing immunotherapy in colorectal cancer.

It's high-time to re-evaluate the value of induced-chemotherapy for reinforcing immunotherapy in colorectal cancer.

Journal: Frontiers in immunology
Published: June 16, 2023

Efficacy of continuous intravenous pumping of insulin for patients with diabetes complicated with perianal abscess and the effect on inflammatory cytokines.

Efficacy of continuous intravenous pumping of insulin for patients with diabetes complicated with perianal abscess and the effect on inflammatory cytokines.

Journal: Experimental and therapeutic medicine
Published: April 15, 2019

Celastrol inhibits colon cancer cell proliferation by downregulating miR-21 and PI3K/AKT/GSK-3β pathway.

Celastrol inhibits colon cancer cell proliferation by downregulating miR-21 and PI3K/AKT/GSK-3β pathway.

Journal: International journal of clinical and experimental pathology
Published: November 06, 2018
Showing 1-12 of 12

Last Updated: 09/26/2026